Do Steroids Affect Blood Sugar?

Corticosteroids are a class of medication commonly used to treat inflammation, allergies, and autoimmune disorders. When people ask if “steroids” affect blood sugar, they are typically referring to these anti-inflammatory drugs, such as prednisone, dexamethasone, and hydrocortisone. These medications mimic the action of cortisol, a hormone naturally produced by the adrenal glands. Corticosteroid use can lead to elevated blood sugar levels, known as steroid-induced hyperglycemia or, in some cases, steroid-induced diabetes. This effect requires careful monitoring, especially in individuals with pre-existing glucose control issues.

The Physiological Mechanism of Hyperglycemia

Corticosteroids elevate blood sugar through two primary biological actions. The first involves increasing the liver’s production of glucose, a process called gluconeogenesis. These drugs signal the liver to release extra stored sugar into the bloodstream, even when the body does not immediately need it. This enhanced glucose production is a major contributor to the rise in blood sugar levels.

The second mechanism centers on reducing the effectiveness of insulin, the hormone responsible for moving sugar from the blood into cells for energy. Corticosteroids induce insulin resistance in muscle and fat tissue, making the cells less responsive to insulin’s signal. Because the body’s cells do not easily accept glucose, the sugar remains trapped in the circulation, further raising blood glucose concentrations.

The timing of this effect is often predictable based on the steroid type and when it is taken. Intermediate-acting oral steroids, such as prednisone, are typically taken in the morning and cause blood sugar levels to rise approximately four to eight hours later. Blood sugar often peaks in the late afternoon or evening, particularly after lunch and before supper. Long-acting steroids, like dexamethasone, can cause persistently high blood sugar levels for 12 to 36 hours.

Patient and Treatment Factors That Increase Risk

Not everyone who takes corticosteroids will experience a significant rise in blood sugar, but certain factors increase an individual’s susceptibility. The most prominent patient-related factor is having a pre-existing condition that affects glucose metabolism. Individuals with Type 2 diabetes or pre-diabetes are at a much higher risk of developing hyperglycemia while on steroid therapy.

Other patient characteristics that increase risk include being over the age of 50, having a history of gestational diabetes, and carrying excess weight. The body’s ability to manage glucose is already strained in these circumstances, and the introduction of corticosteroids further compromises the system. A family history of diabetes also suggests a genetic predisposition to glucose intolerance.

The drug regimen itself introduces several treatment-related risk factors. A higher dose of the steroid is directly correlated with greater risk and severity of hyperglycemia. For instance, a dose of prednisone equivalent to 7.5 milligrams per day or higher is often considered a threshold for increased risk. A longer duration of treatment increases the likelihood of sustained elevated glucose levels.

Practical Strategies for Monitoring and Management

Managing blood sugar while on corticosteroids requires a proactive approach involving frequent monitoring and potential lifestyle or medication adjustments. For those with established diabetes, checking blood sugar four times daily—before each meal and at bedtime—provides the necessary data to track the steroid’s impact. Since the glucose-raising effect often peaks in the afternoon, non-diabetic individuals should consult their healthcare provider about checking glucose levels in the late afternoon or before dinner.

Dietary adjustments are a primary strategy to mitigate post-meal spikes caused by the steroid. It is helpful to avoid simple carbohydrates, such as sugary drinks, sweets, and highly processed foods, which cause rapid glucose increases. Focusing on complex carbohydrates, high-fiber foods, and protein at each meal helps to slow down sugar absorption and stabilize blood glucose. Distributing fruit intake throughout the day instead of consuming large portions at once can also help smooth out glucose curves.

Physical activity serves a therapeutic role by increasing the muscles’ demand for glucose. Engaging in activity after a meal helps move glucose out of the bloodstream and into the cells. This could be as simple as taking a short walk or performing light movements like standing and sitting frequently. Patients should always discuss an exercise plan with their doctor.

If glucose levels remain high despite dietary and exercise changes, medication intervention is often necessary. A healthcare provider may temporarily adjust existing diabetes medication doses or prescribe new agents to manage the hyperglycemia. Insulin is frequently employed because its dosage can be precisely tailored to the degree of blood sugar elevation. Intermediate-acting insulin, for example, may be timed to coincide with the peak effect of a morning dose of prednisone.

Duration and Resolution of Steroid-Induced Blood Sugar Changes

A common concern when high blood sugar develops during steroid treatment is whether the condition is permanent. For most people, the hyperglycemia caused by corticosteroids is temporary and resolves once the medication is tapered or stopped. The return to normal glucose levels often occurs quickly, typically within 24 to 48 hours after the steroid is discontinued.

The temporary nature of the condition means that any insulin or oral medication started to manage the high glucose must also be carefully reduced or stopped. However, steroid therapy may unmask an underlying tendency toward Type 2 diabetes in some individuals. In these cases, the high blood sugar persists even after the steroid is cleared from the body. Healthcare providers often recommend a follow-up glucose test, such as a fasting plasma glucose or oral glucose tolerance test, approximately six weeks after treatment ends to confirm that glucose regulation has normalized.